Skip to content

RuvBL1/2 Gene Therapy for Motor Neurone Disease and Frontotemporal Dementia

Addressing DNA damage and protein aggregation to treat the most common genetic cause of MND/ALS and FTD

Published: 9th March 2021
RuvBL1/2 Gene Therapy for Motor Neurone Disease and Frontotemporal Dementia
vladimircaribb, https://stock.adobe.com/uk/265258529, stock.adobe.com
Patents
  • PCT/EP2021/052378 "Gene Therapy" Priority 12/02/2020
IP Status
  • Patent application submitted
Seeking
  • Development partner
  • Commercial partner
  • Seeking investment